O-GlcNAc: a regulatory post-translational modification

被引:161
作者
Wells, L [1 ]
Whalen, SA [1 ]
Hart, GW [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA
关键词
O-GlcNAc; post-translational modification; transcription; signal transduction; apoptosis; neurodegeneration; nutrient sensing; diabetes; Alzheimer's disease; glycosylation;
D O I
10.1016/S0006-291X(03)00175-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
beta-N-Acetylglucosamine (O-GlcNAc) is a regulatory post-translational modification of nuclear and cytosolic proteins. The enzymes for its addition and removal have recently been cloned and partially characterized. While only about 80 mammalian proteins have been identified to date that carry this modification, it is clear that this represents just a small percentage of the modified proteins. O-GlcNAc has all the properties of a regulatory modification including being dynamic and inducible. The modification appears to modulate transcriptional and signal transduction events. There are also accruing data that O-GlcNAc plays a role in apoptosis and neurodegeneration. A working model is emerging that O-GlcNAc serves as a metabolic sensor that attenuates a cell's response to extracellular stimuli based on the energy state of the cell. In this review, we will focus on the enzymes that add/remove O-GlcNAc, the functional impact of O-GlcNAc modification, and the current working model for O-GlcNAc as a nutrient sensor. (C) 2003 Published by Elsevier Science (USA).
引用
收藏
页码:435 / 441
页数:7
相关论文
共 79 条
[1]   Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules [J].
Alonso, AD ;
GrundkeIqbal, I ;
Iqbal, K .
NATURE MEDICINE, 1996, 2 (07) :783-787
[2]   The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine [J].
Arnold, CS ;
Johnson, GVW ;
Cole, RN ;
Dong, DLY ;
Lee, M ;
Hart, GW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (46) :28741-28744
[3]  
BETRAM L, 2000, SCIENCE, V290, P2302
[4]   TISSUE DISTRIBUTION OF HEXOSAMINIDASE-S AND HEXOSAMINIDASE-C [J].
BEUTLER, E ;
KUHL, W .
ANNALS OF HUMAN GENETICS, 1977, 41 (OCT) :163-167
[5]  
Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.3.CO
[6]  
2-E
[7]   Decreased UDP-GlcNAc levels abrogate proliferation control in EMeg32-deficient cells [J].
Boehmelt, G ;
Wakeham, A ;
Elia, A ;
Sasaki, T ;
Plyte, S ;
Potter, J ;
Yang, YJ ;
Tsang, E ;
Ruland, J ;
Iscove, NN ;
Dennis, JW ;
Mak, TW .
EMBO JOURNAL, 2000, 19 (19) :5092-5104
[8]   Enhanced O-GlcNAc protein modification is associated with insulin resistance in GLUT1-overexpressing muscles [J].
Buse, MG ;
Robinson, KA ;
Marshall, BA ;
Hresko, RC ;
Mueckler, MM .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2002, 283 (02) :E241-E250
[9]   Alternative O-glycosylation/O-phosphorylation of the murine estrogen receptor β [J].
Cheng, XG ;
Cole, RN ;
Zaia, J ;
Hart, GW .
BIOCHEMISTRY, 2000, 39 (38) :11609-11620
[10]   Glycosylation of the murine estrogen receptor-α [J].
Cheng, XG ;
Hart, GW .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2000, 75 (2-3) :147-158